Company profile: Biose
1.1 - Company Overview
Company description
- Provider of pharmaceuticals based on live bacteria, with 60 years of experience and specialized skills across discovery, process development, manufacturing, and registration, focused on health through microbiota and microbiome science.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Biose
A4P Bio
HQ: United Kingdom
Website
- Description: Provider of focused planning solutions and rigorous oversight across the logistics chain, offering bioanalytical project management for pre-clinical and clinical programs; scientific logistics for time- and temperature-sensitive consignments with planning, oversight and real-time monitoring; biosample operations; regulatory compliance and quality systems; laboratory/vendor evaluations; and biomarker strategy consultancy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full A4P Bio company profile →
Sterling Pharma Solutions
HQ: United Kingdom
Website
- Description: Provider of small molecule API development and manufacturing services for the global pharmaceutical industry, from pre-clinical to commercial. Offers ADC pre-clinical bioconjugation services with potent cytotoxin handling; PDMO® collaborative API development and integrated project management; hazardous chemistry; high potency and controlled substance API manufacturing; and peptide API development with large-scale chromatography.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Sterling Pharma Solutions company profile →
SFL
HQ: Switzerland
Website
- Description: Provider of integrated consultancy solutions to pharma, biotech and medtech companies for global and local activities, with in-house expertise across product life cycle functions including Regulatory Affairs & Regulatory Intelligence, Quality & Supply Chain, and Medical Writing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full SFL company profile →
BioStrata
HQ: United Kingdom
Website
- Description: Provider of life science marketing services delivered by a team fluent in scientific and business languages, including brand awareness, lead generation and customer conversion; scientific and technical content creation; SEO (keyword research, content optimization, performance tracking); public relations; and marketing strategy development based on market research and tactical planning.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BioStrata company profile →
CordenPharma
HQ: Switzerland
Website
- Description: Provider of contract development and manufacturing services to pharmaceutical and biotechnology companies, including APIs with development, scale-up and regulatory support; non-sterile and sterile drug products (oral solids, liquids, lyophilized); synthetic lipid excipients (standard and custom); peptide development and manufacturing; and support for bioavailability, LNP formulation/manufacturing, and packaging.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CordenPharma company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Biose
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Biose
2.2 - Growth funds investing in similar companies to Biose
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Biose
4.2 - Public trading comparable groups for Biose
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →